Cited by 476Antiplatelet Therapy and Cardiovascular DiseasesCoronary Interventions and DiagnosticsAcute Myocardial Infarction Research

The DOI matches its Crossref record; 117 of the 118 references it cites were found in a registry or an index.

Primary and Secondary Prevention of Cardiovascular Disease

Open access

Vandvik, Per Olav, Lincoff, A. Michael, Gore, Joel M., Gutterman, David D., Sonnenberg, Frank A., Alonso-Coello, Pablo, Akl, Elie A., Lansberg, Maarten G., Guyatt, Gordon H., Spencer, Frederick A.·2012·Chest

DOI 10.1378/chest.11-2306PMC PMC3278064

Open this paper in CoChat — free account Open PDF

Abstract

Background This guideline focuses on long-term administration of antithrombotic drugs designed for primary and secondary prevention of cardiovascular disease, including two new antiplatelet therapies. Methods The methods of this guideline follow those described in Methodology for the Development of Antithrombotic Therapy and Prevention of Thrombosis Guidelines: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines in this supplement. Results We present 23 recommendations for pertinent clinical questions. For primary prevention of cardiovascular disease, we suggest low-dose aspirin (75-100 mg/d) in patients aged > 50 years over no aspirin therapy (Grade 2B). For patients with established coronary artery disease, defined as patients 1-year post-acute coronary syndrome, with prior revascularization, coronary stenoses > 50% by coronary angiogram, and/or evidence for cardiac ischemia on diagnostic testing, we recommend long-term low-dose aspirin or clopidogrel (75 mg/d) (Grade 1A). For patients with acute coronary syndromes who undergo percutaneous coronary intervention (PCI) with stent placement, we recommend for the first year dual antiplatelet therapy with low-dose aspirin in combination with ticagrelor 90 mg bid, clopidogrel 75 mg/d, or prasugrel 10 mg/d over single antiplatelet therapy (Grade 1B). For patients undergoing elective PCI with stent placement, we recommend aspirin (75-325 mg/d) and clopidogrel for a minimum duration of 1 month (bare-metal stents) or 3 to 6 months (drug-eluting stents) (Grade 1A). We suggest continuing low-dose aspirin plus clopidogrel for 12 months for all stents (Grade 2C). Thereafter, we recommend single antiplatelet therapy over continuation of dual antiplatelet therapy (Grade 1B). Conclusions Recommendations continue to favor single antiplatelet therapy for patients with established coronary artery disease. For patients with acute coronary syndromes or undergoing elective PCI with stent placement, dual antiplatelet therapy for up to 1 year is warranted.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1378/chest.11-2306

Cites

117 of 117 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

1 retracted

Antiplatelet agents versus control or anticoagulation for heart failure in sinus rhythm
Lip, G. Y. H., Wrigley, B., & Pisters, R. (2000) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003333 · Cited by 32
Retracted
Prediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581
Ticagrelor versus clopidogrel in patients with acute coronary syndromes
Wallentin, L., Becker, R. C., Budaj, A., Cannon, C. P., Emanuelsson, H., Held, C., Horrow, J., Husted, S., James, S., Katus, H., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0904327 · Cited by 7,117
Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients
Collaboration, A. T. (2002) · BMJ · doi:10.1136/bmj.324.7329.71 · Cited by 6,943
Prasugrel versus clopidogrel in patients with acute coronary syndromes
Wiviott, S. D., Braunwald, E., McCabe, C. H., Montalescot, G., Ruzyllo, W., Gottlieb, S., Neumann, F.-J., Ardissino, D., De Servi, S., Murphy, S. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa0706482 · Cited by 6,790
A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)
(1996) · The Lancet · doi:10.1016/s0140-6736(96)09457-3 · Cited by 6,503
Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation
(2001) · New England Journal of Medicine · doi:10.1056/nejmoa010746 · Cited by 6,470
Untitled work
Kearon (2012) · doi:10.1378/chest.11-2301 · Cited by 6,119
Self-citation
Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the hypertension optimal treatment (HOT) randomised trial
Hansson, L., Zanchetti, A., Carruthers, S. G., Dahlöf, B., Elmfeldt, D., Julius, S., Ménard, J., Rahn, K. H., Wedel, H., & Westerling, S. (1998) · The Lancet · doi:10.1016/s0140-6736(98)04311-6 · Cited by 5,728
Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials
(2009) · The Lancet · doi:10.1016/s0140-6736(09)60503-1 · Cited by 3,675
Incidence, Predictors, and Outcome of Thrombosis After Successful Implantation of Drug-Eluting Stents
Iakovou, I. P. (2005) · JAMA · doi:10.1001/jama.293.17.2126 · Cited by 3,136
Early and Sustained Dual Oral Antiplatelet Therapy Following Percutaneous Coronary Intervention
Steinhubl, S. R., Berger, P. B., Mann, J. T., Fry, E. T. A., DeLago, A. J., Wilmer, C. I., Topol, E. J., & for the CREDO Investigators (2002) · JAMA · doi:10.1001/jama.288.19.2411 · Cited by 3,071
Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study
Mehta, S. R., Yusuf, S., Peters, R. J. G., Bertrand, M. E., Lewis, B. S., Natarajan, M. K., Malmberg, K., Rupprecht, H.-J., Zhao, F., Chrolavicius, S., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05701-4 · Cited by 2,937
Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic Events
Bhatt, D. L., Fox, K. A. A., Hacke, W., Berger, P. B., Black, H. R., Boden, W. E., Cacoub, P., Cohen, E. A., Creager, M. A., Easton, J. D., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa060989 · Cited by 2,819
A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee
Dennis, M. S. (1996) · The Lancet · Cited by 2,728
Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study
Mehta, S. R., Yusuf, S., & Peters, R. J. G. (2002) · ACC Current Journal Review · doi:10.1016/s1062-1458(02)00559-7 · Cited by 2,579
Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial
Diener, H.-C., Bogousslavsky, J., Brass, L. M., Cimminiello, C., Csiba, L., Kaste, M., Leys, D., Matias-Guiu, J., & Rupprecht, H.-J. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16721-4 · Cited by 2,275
Final Report on the Aspirin Component of the Ongoing Physicians' Health Study
Steering Committee of the Physicians' Health Study Research Group (1989) · New England Journal of Medicine · doi:10.1056/nejm198907203210301 · Cited by 2,267
Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty).
Ryan, T. J., Faxon, D. P., Gunnar, R. M., Kennedy, J. W., King, S. B., Loop, F. D., Peterson, K. L., Reeves, T. J., Williams, D. O., & Winters, W. L. (1988) · Circulation · doi:10.1161/01.cir.78.2.486 · Cited by 2,123
A Randomized Trial of Low-Dose Aspirin in the Primary Prevention of Cardiovascular Disease in Women
Ridker, P. M., Cook, N. R., Lee, I.-M., Gordon, D., Gaziano, J. M., Manson, J. E., Hennekens, C. H., & Buring, J. E. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050613 · Cited by 1,945
Perioperative Management of Antithrombotic Therapy
Douketis, J. D., Spyropoulos, A. C., Spencer, F. A., Mayr, M., Jaffer, A. K., Eckman, M. H., Dunn, A. S., & Kunz, R. (2012) · CHEST Journal · doi:10.1378/chest.11-2298 · Cited by 1,658
Self-citation
Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary
Rydén, L., Standl, E., Bartnik, M., den Berghe, G. V., Betteridge, J. D., de Boer, M., Cosentino, F., Jönsson, B., Laakso, M., Malmberg, K., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehl260 · Cited by 1,644
Guidelines for Percutaneous Coronary Interventions
Silber, S., Albertsson, P., Fernández‐Avilés, F., Camici, P. G., Colombo, A., Hamm, C. W., Jørgensen, E. O., Marco, J., Nordrehaug, J.-E., Rużyłło, W., et al. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi138 · Cited by 1,607
Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials
Rothwell, P. M., Fowkes, F. G. R., Belch, J. F., Ogawa, H., Warlow, C. P., & Meade, T. W. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62110-1 · Cited by 1,497
Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis
Stettler, C., Wandel, S., Allemann, S., Kastrati, A., Morice, M., Schömig, A., Pfisterer, M. E., Stone, G. W., Leon, M. B., de Lezo, J. S., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61444-5 · Cited by 1,435
Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials
Rothwell, P. M., Wilson, M., Elwin, C.-E., Norrving, B., Algra, A., Warlow, C. P., & Meade, T. W. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61543-7 · Cited by 1,351
Late Clinical Events After Clopidogrel Discontinuation May Limit the Benefit of Drug-Eluting Stents
Pfisterer, M. E., Rocca, H. B., Buser, P. T., Rickenbacher, P. R., Hunziker, P., Mueller, C. E., Jeger, R. V., Bader, F., Osswald, S., & Kaiser, C. A. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.10.026 · Cited by 1,303
Randomised trial of prophylactic daily aspirin in British male doctors
Peto, R., Gray, R. G., Collins, R., Wheatley, K., Hennekens, C. H., Jamrozik, K. D., Warlow, C., Hafner, B., Thompson, E., Norton, S., et al. (1988) · BMJ · doi:10.1136/bmj.296.6618.313 · Cited by 1,164
Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus
Buse, J. B., Ginsberg, H. N., Bakris, G. L., Clark, N. G., Costa, F., Eckel, R., Fonseca, V., Gerstein, H. C., Grundy, S., Nesto, R. W., et al. (2007) · Diabetes Care · doi:10.2337/dc07-9917 · Cited by 1,055
2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention
King, S. B., Smith, S. C., Hirshfeld, J. W., Jacobs, A. K., Morrison, D. A., Williams, D. O., Smith, S. C., Feldman, T. E., Hirshfeld, J. W., Jacobs, A. K., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.188208 · Cited by 1,008
Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general Practice
Roncaglioni, M. C. (2001) · The Lancet · doi:10.1016/s0140-6736(00)03539-x · Cited by 993
The Effect of Aggressive Lowering of Low-Density Lipoprotein Cholesterol Levels and Low-Dose Anticoagulation on Obstructive Changes in Saphenous-Vein Coronary-Artery Bypass Grafts
The Post Coronary Artery Bypass Graft Trial Investigators (1997) · New England Journal of Medicine · doi:10.1056/nejm199701163360301 · Cited by 969
Antithrombotic Therapy for Atrial Fibrillation
You, J. J., Singer, D. E., Howard, P. A., Lane, D. A., Eckman, M. H., Fang, M. C., Hylek, E. M., Schulman, S., Go, A. S., Hughes, M., et al. (2012) · CHEST Journal · doi:10.1378/chest.11-2304 · Cited by 933
Self-citation
Clopidogrel Use and Long-term Clinical Outcomes After Drug-Eluting Stent Implantation
Eisenstein, E. L., Anstrom, K. J., Kong, D. F., Shaw, L. K., Tuttle, R. H., Mark, D. B., Kramer, J. M., Harrington, R. A., Matchar, D. B., Kandzari, D. E., et al. (2006) · JAMA · doi:10.1001/jama.297.2.joc60179 · Cited by 868
Prevalence, Predictors, and Outcomes of Premature Discontinuation of Thienopyridine Therapy After Drug-Eluting Stent Placement
Spertus, J. A., Kettelkamp, R., Vance, C., Decker, C., Jones, P. G., Rumsfeld, J. S., Messenger, J. C., Khanal, S., Peterson, E. D., Bach, R. G., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.618066 · Cited by 853
Warfarin, Aspirin, or Both after Myocardial Infarction
Hurlen, M., Abdelnoor, M., Smith, P., Erikssen, J., & Arnesen, H. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020496 · Cited by 846
Benefits and Risks of the Combination of Clopidogrel and Aspirin in Patients Undergoing Surgical Revascularization for Non–ST-Elevation Acute Coronary Syndrome
Fox, K. A. A., Mehta, S. R., Peters, R. J. G., Zhao, F., Lakkis, N. M., Gersh, B. J., & Yusuf, S. (2004) · Circulation · doi:10.1161/01.cir.0000140675.85342.1b · Cited by 838
Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk
(1998) · The Lancet · doi:10.1016/s0140-6736(97)11475-1 · Cited by 829
Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial
Mehta, S. R., Tanguay, J., Eikelboom, J. W., Jolly, S. S., Joyner, C. D., Granger, C. B., Faxon, D. P., Rupprecht, H., Budaj, A., Avezum, Á., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61088-4 · Cited by 812
Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analyses
Sun, X., Briel, M., Walter, S. D., & Guyatt, G. H. (2010) · BMJ · doi:10.1136/bmj.c117 · Cited by 808
Self-citation
Dose Comparisons of Clopidogrel and Aspirin in Acute Coronary Syndromes
The CURRENT–OASIS 7 Investigators (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0909475 · Cited by 767
Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist AZD6140 with aspirin in patients with atherosclerosis: a double-blind comparison to clopidogrel with aspirin
Husted, S., Emanuelsson, H., Heptinstall, S., Sandset, P. M., Wickens, M., & Peters, G. R. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehi754 · Cited by 741
Angiographic Follow-up after Placement of a Self-Expanding Coronary-Artery Stent
Serruys, P. W. J. C., Strauss, B. H., Beatt, K. J., Bertrand, M. E., Puel, J., Rickards, A. F., Meier, B., Goy, J., Vogt, P., KAPPENBERGER, L. J., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199101033240103 · Cited by 732
Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study
Cannon, C. P., Harrington, R. A., James, S. K., Ardissino, D., Becker, R. C., Emanuelsson, H., Husted, S., Katus, H. A., Keltai, M., Khurmi, N. S., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(09)62191-7 · Cited by 665
2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention
King, S. B., Smith, S. C., Hirshfeld, J. W., Morrison, D. A., Williams, D. O., & Jacobs, A. K. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.10.002 · Cited by 611
Incidence of Left-Ventricular Thrombosis after Acute Transmural Myocardial Infarction
ASINGER, R. W., Mikell, F. L., Elsperger, J., & Hodges, M. (1981) · New England Journal of Medicine · doi:10.1056/nejm198108063050601 · Cited by 580
Intracoronary stenting for acute and threatened closure complicating percutaneous transluminal coronary angioplasty.
Roubin, G. S., Cannon, A. D., Agrawal, S. K., Macander, P. J., Dean, L. S., Baxley, W. A., & Breland, J. (1992) · Circulation · doi:10.1161/01.cir.85.3.916 · Cited by 580
Duration of Dual Antiplatelet Therapy after Implantation of Drug-Eluting Stents
Park, S., Park, D. W., Kim, Y. H., Kang, S.-J., Lee, S., Lee, C. W., Han, K. H., Park, S. W., Yun, S., Lee, S. G., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001266 · Cited by 512
Inhibition of Platelet Aggregation by AZD6140, A Reversible Oral P2Y12Receptor Antagonist, Compared With Clopidogrel in Patients With Acute Coronary Syndromes
Storey, R. F., Husted, S., Harrington, R. A., Heptinstall, S., Wilcox, R. G., Peters, G. R., Wickens, M., Emanuelsson, H., Gurbel, P. A., Grande, P., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.07.058 · Cited by 482
Aspirin Dose for the Prevention of Cardiovascular Disease: A Systematic Review
Campbell, C. L., Smyth, S., Montalescot, G., & Steinhubl, S. R. (2007) · JAMA · doi:10.1001/jama.297.18.2018 · Cited by 444
Oral Anticoagulant and Antiplatelet Therapy and Peripheral Arterial Disease
(2007) · New England Journal of Medicine · doi:10.1056/nejmoa065959 · Cited by 442
Embolic potential, prevention and management of mural thrombus complicating anterior myocardial infarction: A meta-analysis
Vaitkus, P. T., & Barnathan, E. S. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90409-t · Cited by 430
Aspirin and coumadin after acute coronary syndromes (the ASPECT-2 study): a randomised controlled trial
van Es, R. F., Jonker, J. J. C., Verheugt, F. W. A., Deckers, J. W., & Grobbee, D. E. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09409-6 · Cited by 420
Randomized Trial of Warfarin, Aspirin, and Clopidogrel in Patients With Chronic Heart Failure
Massie, B. M., Collins, J. F., Ammon, S. E., Armstrong, P. W., Cleland, J. G. F., Ezekowitz, M. D., Jafri, S. M., Krol, W. F., O’Connor, C. M., Schulman, K. A., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.801753 · Cited by 413
The Warfarin/Aspirin study in heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure
Cleland, J. G. F., Findlay, I., Jafri, S. M., Sutton, G. C., Falk, R. H., Bulpitt, C., Prentice, C. R. M., Ford, I., Trainer, A., & Poole-Wilson, P. A. (2004) · American Heart Journal · doi:10.1016/j.ahj.2004.03.010 · Cited by 407
Aspirin Therapy in Diabetes
Colwell, J. A. (1997) · Diabetes Care · doi:10.2337/diacare.20.11.1767 · Cited by 399
Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials
De Berardis, G., Sacco, M., Strippoli, G. F. M., Pellegrini, F., Graziano, G., Tognoni, G., & Nicolucci, A. (2009) · BMJ · doi:10.1136/bmj.b4531 · Cited by 395
A Meta-Analysis of 16 Randomized Trials of Sirolimus-Eluting Stents Versus Paclitaxel-Eluting Stents in Patients With Coronary Artery Disease
Schömig, A., Dibra, A., Windecker, S., Mehilli, J., de Lezo, J. S., Kaiser, C. A., Park, S., Goy, J., Lee, J., Lorenzo, E. D., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.06.047 · Cited by 363
Stent Thrombosis After Successful Sirolimus-Eluting Stent Implantation
Jeremias, A., Sylvia, B., Bridges, J., Kirtane, A. J., Bigelow, B., Pinto, D. S., Ho, K. K. L., Cohen, D. J., Garcia, L. A., Cutlip, D. E., et al. (2004) · Circulation · doi:10.1161/01.cir.0000127105.99982.21 · Cited by 350
Analysis of Risk of Bleeding Complications After Different Doses of Aspirin in 192,036 Patients Enrolled in 31 Randomized Controlled Trials
Serebruany, V. L., Steinhubl, S. R., Berger, P. B., Malinin, A. I., Baggish, J. S., Bhatt, D. L., & Topol, E. J. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.01.049 · Cited by 343
Use of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study
de Ruijter, W., Westendorp, R. G. J., Assendelft, W. J. J., den Elzen, W. P. J., de Craen, A. J. M., le Cessie, S., & Gussekloo, J. (2009) · BMJ · doi:10.1136/bmj.a3083 · Cited by 339
Warfarin plus Aspirin after Myocardial Infarction or the Acute Coronary Syndrome: Meta-Analysis with Estimates of Risk and Benefit
Rothberg, M. B., Celestin, C., Fiore, L. D., Lawler, E. V., & Cook, J. R. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-143-4-200508160-00005 · Cited by 335
EVALUATE hysterectomy trial: a multicentre randomised trial comparing abdominal, vaginal and laparoscopic methods of hysterectomy
Garry, R., Fountain, J., Brown, J. M., Manca, A., Mason, S. M., Sculpher, M., Napp, V., Bridgman, S., Gray, J., & Lilford, R. J. (2004) · Health Technology Assessment · doi:10.3310/hta8260 · Cited by 303
Randomised double-blind trial of fixed low-dose warfarin with aspirin after myocardial infarction
(1997) · The Lancet · doi:10.1016/s0140-6736(97)01180-x · Cited by 303
Left Ventricular Mural Thrombi Complicating Acute Myocardial Infarction
Weinreich, D. J., BURKE, J. F., & PAULETTO, F. J. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-100-6-789 · Cited by 267
Patient Values and Preferences in Decision Making for Antithrombotic Therapy: A Systematic Review
MacLean, S., Mulla, S. M., Akl, E. A., Jankowski, M., Vandvik, P. O., Ebrahim, S., McLeod, S. L., Bhatnagar, N., & Guyatt, G. H. (2012) · CHEST Journal · doi:10.1378/chest.11-2290 · Cited by 252
Self-citation
Methodology for the Development of Antithrombotic Therapy and Prevention of Thrombosis Guidelines
Guyatt, G. H., Norris, S. L., Schulman, S., Hirsh, J., Eckman, M. H., Akl, E. A., Crowther, M. A., Vandvik, P. O., Eikelboom, J. W., McDonagh, M. S., et al. (2012) · CHEST Journal · doi:10.1378/chest.11-2288 · Cited by 250
Self-citation
Natural history of left ventricular thrombi: Their appearance and resolution in the posthospitalization period of acute myocardial infarction
Keren, A., Goldberg, S., Gottlieb, S., Klein, J., Schuger, C. D., Medina, A., Tzivoni, D., & Stern, S. (1990) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(90)90275-t · Cited by 247
Guidelines on Diabetes, Pre-Diabetes, and Cardiovascular Diseases: Executive Summary
Rydén, L., Standl, E., Bartnik, M., den Berghe, G. V., Betteridge, J. D., de Boer, M., Cosentino, F., Jönsson, B., Laakso, M., Malmberg, K., et al. (2007) · Revista Española de Cardiología (English Edition) · doi:10.1016/s1885-5857(07)60205-9 · Cited by 242
Risks and Benefits of Oral Anticoagulation Compared With Clopidogrel Plus Aspirin in Patients With Atrial Fibrillation According to Stroke Risk
Healey, J. S., Hart, R. G., Pogue, J. M., Pfeffer, M. A., Hohnloser, S. H., Caterina, R. D., Flaker, G., Yusuf, S., & Connolly, S. J. (2008) · Stroke · doi:10.1161/strokeaha.107.500199 · Cited by 225
Efficacy of Antithrombotic Therapy in Chronic Heart Failure: The HELAS Study
Cokkinos, D. V., Haralabopoulos, G. C., Kostis, J. B., TOUTOUZAS, P. K., & for the HELAS investigators (2006) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2006.02.012 · Cited by 223
Benefits, morbidity, and mortality associated with long-term administration of oral anticoagulant therapy to patients with peripheral arterial bypass procedures: A prospective randomized study
Johnson, W. C., & Williford, W. O. (2002) · Journal of Vascular Surgery · doi:10.1067/mva.2002.121847 · Cited by 213
[Guidelines for percutaneous coronary interventions].
Silber, S., Albertsson, P., Fernández‐Avilés, F., Camici, P. G., Colombo, A., Hamm, C. W., Jørgensen, E. O., Marco, J., Nordrehaug, J.-E., Rużyłło, W., et al. (2005) · PubMed · Cited by 201
Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk. The Medical Research Council's General Practice Research Framework.
(1998) · PubMed · Cited by 200
Multicenter Randomized Trial Evaluating the Efficacy of Cilostazol on Ischemic Vascular Complications After Drug-Eluting Stent Implantation for Coronary Heart Disease
Suh, J., Lee, S., Park, K. W., Lee, H., Kang, H., Koo, B., Cho, Y., Youn, T., Chae, I., Choi, D., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.08.631 · Cited by 193
An independent external validation and evaluation of QRISK cardiovascular risk prediction: a prospective open cohort study
Collins, P. G. S., & Altman, D. G. (2009) · BMJ · doi:10.1136/bmj.b2584 · Cited by 192
Warfarin improves the outcome of infrainguinal vein bypass grafting at high risk for failure
Sarac, T. P., Huber, T. S., Back, M. R., Ozaki, C. K., Carlton, L. M., Flynn, T. C., & Seeger, J. M. (1998) · Journal of Vascular Surgery · doi:10.1016/s0741-5214(98)70130-2 · Cited by 171
Effect of Aspirin on Mortality in the Primary Prevention of Cardiovascular Disease
Raju, N. C., Sobieraj‐Teague, M., Hirsh, J., O'Donnell, M. J., & Eikelboom, J. W. (2011) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.01.018 · Cited by 170
Frequency of Left Ventricular Thrombus in Patients With Anterior Wall Acute Myocardial Infarction Treated With Percutaneous Coronary Intervention and Dual Antiplatelet Therapy
Solheim, S., Seljeflot, I., Lunde, K., Bjørnerheim, R., Aakhus, S., Forfang, K., & Arnesen, H. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.06.043 · Cited by 165
Aspirin for primary prevention of cardiovascular events in patients with diabetes: A meta-analysis
Zhang, C., Sun, A., Zhang, P., Wu, C., Zhang, S., Fu, M., Wang, K., Zou, Y., & Ge, J. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.09.029 · Cited by 150
Neointimal coverage of stents in human coronary arteries observed by angioscopy
Ueda, Y., Nanto, S., Komamura, K., & Kodama, K. (1994) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)90417-0 · Cited by 148
BASKET-LATE INVESTIGATORS, LATE CLINICAL EVENTS AFTER CLOPIDOGREL DISCONTINUATION MAY LIMIT THE BENEFIT OF DRUGELUTING STENTS: AN OBSERVATIONAL STUDY OF DRUG-ELUTING VERSUS BARE-METAL STENTS
PFISTERER, M. E., Rocca, H. B., Buser, P. T., Rickenbacher, P. R., Hunziker, P., Mueller, C., Jeger, R. V., Bader, F., Osswald, S., & Kaiser, C. (2006) · Cited by 143
Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular events
Squizzato, A., Bellesini, M., Takeda, A., Middeldorp, S., & Donadini, M. P. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005158.pub4 · Cited by 142
Effects of aspirin dose on ischaemic events and bleeding after percutaneous coronary intervention: insights from the PCI-CURE study
Jolly, S. S., Pogue, J. M., Haladyn, K., Peters, R. J. G., Fox, K. A. A., Avezum, Á., Gersh, B. J., Rupprecht, H. J., Yusuf, S., & Mehta, S. R. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn417 · Cited by 133
Clopidogrel used in combination with aspirin compared with aspirin alone in the treatment of non-ST-segment-elevation acute coronary syndromes: a systematic review and economic evaluation
Main, C., Palmer, S. C., Griffin, S. C., Jones, L., Orton, V., Sculpher, M. J., Henderson, R., Sudlow, C. L. M., Hawkins, N., & Riemsma, R. P. (2004) · Health Technology Assessment · doi:10.3310/hta8400 · Cited by 125
Aspirin Therapy in Diabetes
American Diabetes Association (2003) · Diabetes Care · doi:10.2337/diacare.26.2007.s87 · Cited by 122
Systematic review and meta-analysis of randomized clinical trials appraising the impact of cilostazol after percutaneous coronary intervention
Biondi‐Zoccai, G., Lotrionte, M., Anselmino, M., Moretti, C., Agostoni, P., Testa, L., Abbate, A., Cosgrave, J., Laudito, A., Trevi, G. P., et al. (2008) · American Heart Journal · doi:10.1016/j.ahj.2007.12.024 · Cited by 114
Long-Term Oral Anticoagulant Therapy in Patients With Unstable Angina or Suspected Non–Q-Wave Myocardial Infarction
Anand, S. S., Yusuf, S., Pogue, J. M., Weitz, J. I., & Flather, M. D. (1998) · Circulation · doi:10.1161/01.cir.98.11.1064 · Cited by 112
Incidence of early left ventricular thrombus after acute anterior wall myocardial infarction in the primary coronary intervention era
Osherov, A. B., Borovik-Raz, M., Aronson, D., Agmon, Y., Kapeliovich, M. R., Kerner, A., Grenadier, E., Hammerman, H., Nikolsky, E., & Roguin, A. (2009) · American Heart Journal · doi:10.1016/j.ahj.2009.03.020 · Cited by 109
Long-term cost-effectiveness of clopidogrel given for up to one year in patients with acute coronary syndromes without ST-segment elevation
Weintraub, W. S., Mahoney, E. M., Lamy, A. L., Culler, S. D., Yuan, Y., Jaime, J., Gabriel, S., & Yusuf, S. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.11.051 · Cited by 106
Weighing Benefits and Risks — The FDA's Review of Prasugrel
Unger, E. F. (2009) · New England Journal of Medicine · doi:10.1056/nejmp0907122 · Cited by 105
A Cost-Effectiveness Analysis of Combination Antiplatelet Therapy for High-Risk Acute Coronary Syndromes: Clopidogrel plus Aspirin versus Aspirin Alone
Schleinitz, M. D., & Heidenreich, P. A. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-4-200502150-00007 · Cited by 100
Left ventricular thrombus formation after first anterior wall acute myocardial infarction
Lamas, G. A., Vaughan, D. E., & Pfeffer, M. A. (1988) · The American Journal of Cardiology · doi:10.1016/0002-9149(88)91360-4 · Cited by 97
Duration of Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents
Park, S., Park, D., Kim, Y., Kang, S., Lee, S., Lee, C. W., Han, K., Park, S., Yun, S.-C., Lee, S.-G., et al. (2011) · Survey of Anesthesiology · doi:10.1097/01.sa.0000391589.20506.f0 · Cited by 94
Clopidogrel versus aspirin for secondary prophylaxis of vascular events: a cost-effectiveness analysis
Schleinitz, M. D., Weiss, J. P., & Owens, D. K. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.01.014 · Cited by 93
Thrombosis and restenosis after stenting in failed angioplasty: Comparison with elective stenting
Foley, J. B., Brown, R. I. G., & Penn, I. M. (1994) · American Heart Journal · doi:10.1016/0002-8703(94)90004-3 · Cited by 89
Efficacy of Cilostazol in reducing restenosis in patients undergoing contemporary stent based PCI: a meta-analysis of randomised controlled trials
Tamhane, U. U., Meier, P., Chetcuti, S. J., Chen, K., Rha, S., Grossman, P. M., & Gurm, H. S. (2009) · EuroIntervention · doi:10.4244/v5i3a60 · Cited by 75
Thienopyridine derivatives versus aspirin for preventing stroke and other serious vascular events in high vascular risk patients
Sudlow, C. L. M., Mason, G., Maurice, J. B., Wedderburn, C. J., & Hankey, G. J. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001246.pub2 · Cited by 71
Early Stent Thrombosis
Cook, S., & Windecker, S. (2009) · Circulation · doi:10.1161/circulationaha.108.842757 · Cited by 68
Cost-effectiveness of New Antiplatelet Regimens Used as Secondary Prevention of Stroke or Transient Ischemic Attack
Sarasin, F., Gaspoz, J., & Bounameaux, H. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.18.2773 · Cited by 67
Aspirin for everyone older than 50?
Elwood, P. C., Morgan, G., Brown, G., & Pickering, J. E. (2005) · BMJ · doi:10.1136/bmj.330.7505.1440 · Cited by 54
Cost‐effectiveness of clopidogrel in acute coronary syndromes in Sweden: a long‐term model based on the cure trial
Lindgren, P., Jönsson, B., & Yusuf, S. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01324.x · Cited by 48
The cost-effectiveness of the use of clopidogrel in acute coronary syndromes in five countries based upon the CURE study
Lamy, A. L., Jönsson, B., Weintraub, W. S., Zhao, F., Chrolavicius, S., Bakhai, A., Culler, S. D., Gafni, A., Lindgren, P., Mahoney, E. M., et al. (2004) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/00149831-200412000-00003 · Cited by 47
Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular disease
Squizzato, A., Keller, T. T., & Middeldorp, S. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005158.pub2 · Cited by 45
Effects of warfarin on markers of hypercoagulability in patients with heart failure
Jafri, S. M., Mammen, E. F., Masura, J., & Goldstein, S. (1997) · American Heart Journal · doi:10.1016/s0002-8703(97)70103-0 · Cited by 39
Comparison of long-term usefulness of clopidogrel therapy after the first percutaneous coronary intervention or coronary artery bypass grafting versus that after the second or repeat intervention
Saw, J., Topol, E. J., Steinhubl, S. R., Brennan, D. M., Berger, P. B., & Moliterno, D. J. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.05.026 · Cited by 38
Randomised double-blind trial of fixed low-dose warfarin with aspirin after myocardial infarction. Coumadin Aspirin Reinfarction Study (CARS) Investigators.
(1997) · PubMed · Cited by 36
Ticlopidine versus oral anticoagulation for coronary stenting
Cosmi, B., Rubboli, A., Castelvetri, C., & Milandri, M. (2001) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002133 · Cited by 34
Evidence for Using Clopidogrel Alone or in Addition to Aspirin in Post Coronary Artery Bypass Surgery Patients
Patel, J., Stoner, J. A., Owora, A. H., Mathew, S. T., & Thadani, U. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.02.021 · Cited by 33
Long-Term Versus Short-Term Clopidogrel Therapy in Patients Undergoing Coronary Stenting (from the Randomized Argentine Clopidogrel Stent [RACS] Trial)
Bernardi, V., Szarfer, J., Summay, G., Méndiz, O., Sarmiento, R., Alemparte, M. J. R., Gabay, J. M., & Berger, P. B. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.08.034 · Cited by 30
A cost-utility analysis of clopidogrel in patients with non-ST-segment-elevation acute coronary syndromes in the UK
Karnon, J. D., Bakhai, A., Brennan, A., Pandor, A., Flather, M. D., Warren, E., Gray, D., & Akehurst, R. L. (2005) · International Journal of Cardiology · doi:10.1016/j.ijcard.2005.06.026 · Cited by 29
The Value of Clopidogrel versus Aspirin in Reducing Atherothrombotic Events
Durand‐Zaleski, I., & Bertrand, M. E. (2004) · PharmacoEconomics · doi:10.2165/00019053-200422004-00005 · Cited by 28
Warfarin after anterior myocardial infarction in current era of dual antiplatelet therapy: a randomized feasibility trial
Schwalm, J.-D. R., Ahmad, M., Salehian, O., Eikelboom, J. W., & Natarajan, M. K. (2010) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-010-0448-6 · Cited by 24
Age threshold for vascular prophylaxis by aspirin in patients without diabetes
Bulugahapitiya, U., Siyambalapitiya, S., Sithole, J., Fernando, D., & Idris, I. (2008) · Heart · doi:10.1136/hrt.2008.150698 · Cited by 21
Long-term peripheral stent evaluation using angioscopy.
Bergeron, P., Rudondy, P., Poyen, V., Pinot, J. J., Alessandri, C., & Jp, M. (1991) · PubMed · Cited by 21
A comparison of 1-month and 6-month clopidogrel therapy on clinical and angiographic outcome after stent implantation
Pekdemir, H., Cin, V. G., Çamsarı, A., Çiçek, D., Akkuş, M. N., Döven, O., & Parmaksız, T. (2003) · Heart and Vessels · doi:10.1007/s00380-003-0704-1 · Cited by 17
The effect of long-term clopidogrel use on neointimal formation after percutaneous coronary intervention
Akbulut, M., Özbay, Y., Karaca, I., İlkay, E., Gündoğdu, Ö., & Arslan, N. (2004) · Coronary Artery Disease · doi:10.1097/00019501-200409000-00008 · Cited by 16

Flagged first, then by citations

1 of the 118 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

Wilson, 1998, Prediction of coronary artery disease using risk factor categories, Circulation, 97, 1837, 10.1161/01.CIR.97.18.1837 · DOI · Paper page

Sorted by citations

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P. F., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castellà, M., Diener, H., Heidbüchel, H., Hendriks, J., et al. (2016) · EP Europace · doi:10.1093/europace/euw295 · Cited by 6,439
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw210 · Cited by 6,418
Untitled work
Kearon (2012) · doi:10.1378/chest.11-2301 · Cited by 6,119
Self-citation
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
Kernan, W. N., Ovbiagele, B., Black, H. R., Bravata, D. M., Chimowitz, M. I., Ezekowitz, M. D., Fang, M. C., Fisher, M., Furie, K. L., Heck, D. V., et al. (2014) · Stroke · doi:10.1161/str.0000000000000024 · Cited by 5,170
2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction
O’Gara, P. T., Kushner, F. G., Ascheim, D. D., Casey, D. E., Chung, M. K., de Lemos, J. A., Ettinger, S. M., Fang, J. C.-T., Fesmire, F. M., Franklin, B. A., et al. (2012) · Circulation · doi:10.1161/cir.0b013e3182742cf6 · Cited by 4,802

See all 476

Authors: Vandvik, P. O., Lincoff, A. M., Gore, J. M., Gutterman, D. D., Sonnenberg, F. A., Alonso-Coello, P., Akl, E. A., Lansberg, M. G., Guyatt, G. H., & Spencer, F. A.
Affiliations: Innlandet Hospital Trust (NO)
Cleveland Clinic (US)
University of Massachusetts Chan Medical School (US)
Medical College of Wisconsin (US)
University of Medicine and Dentistry of New Jersey (US)
University at Buffalo, State University of New York (US)
Stanford Medicine (US)
McMaster University (CA)
Corresponding author: Spencer, Frederick A.
ORCID: Vandvik, Per Olav
Lincoff, A. Michael
Gutterman, David D.
Sonnenberg, Frank A.
Akl, Elie A.
Lansberg, Maarten G.
Guyatt, Gordon H.
Spencer, Frederick A.
Venue: Chest
Publisher: Elsevier BV
Published: 2012-02
Volume: 141
Issue: 2
Pages: e637S-e668S
ISSN: 0012-3692 (ISSN-L)
DOI: 10.1378/chest.11-2306
PMC: PMC3278064
OpenAlex: W2116051185
Cited by: 476
References: 118
Citations by year: 2026: 3 · 2025: 7 · 2024: 11 · 2023: 6 · 2022: 23 · 2021: 19 · 2020: 32 · 2019: 36 · 2018: 29 · 2017: 44 · 2016: 46 · 2015: 59 · 2014: 58 · 2013: 64 · 2012: 37
FWCI: 44.86
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
Locations: CHEST Journal (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: Bristol-Myers Squibb
Sanofi
National Heart, Lung, and Blood Institute (R13HL104758)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Antiplatelet Therapy and Cardiovascular Diseases
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Coronary Interventions and Diagnostics
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
Keywords: cardiovascular disease prevention, antithrombotic therapy, antiplatelet therapy, low-dose aspirin, clopidogrel, ticagrelor, prasugrel, dual antiplatelet therapy, single antiplatelet therapy, acute coronary syndrome, percutaneous coronary intervention, coronary artery disease, drug-eluting stents, bare-metal stents, long-term aspirin therapy
MeSH terms: Aged, Cardiovascular Diseases, Combined Modality Therapy, Coronary Disease, Dose-Response Relationship, Drug, Drug Therapy, Combination, Fibrinolytic Agents, Humans, Long-Term Care, Middle Aged, Platelet Aggregation Inhibitors, Risk Factors, Societies, Medical, Thrombosis, Stents, Angioplasty, Balloon, Coronary, Myocardial Ischemia, Evidence-Based Medicine, Secondary Prevention

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Primary and Secondary Prevention of Cardiovascular Disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks